Thread about the unicorn of the OTC $ACMB
From the ACMB website, there is a link to 'Starlink Securities'
ACMB website: https://t.co/R9SYdPBc6X
Starlink Securities: https://t.co/pL1BPk2JBr
Starlink six major divisions:
- Underwriting Division
- Proprietary Trading & Investment Division
- USD Asset Trust Division
- Asset Management Division
- Securities Advisory Division
- Real World Asset Underwriting Division
Pay attention to the co-founders. You will get very familiar with them.
Thread about $ACMB. This could be one of the rarest plays in OTC with a clear plan to go Nasdaq, real-world biotech assets on blockchain, and an experienced team driving it.
Translated videos from their Chinese marketing partner below. 🧵👇
Could be a few reasons. They may be done raising capital, could be closing in on uplisting, realizing it’s has no effect on OTC stock and has no upside. Hard to say but I think it’s a good thing not negative
The OTC chart is a mirage there was never any real volume. I’ve been saying it all along it makes no sense that they had linked any of the Taiwan PR or videos unless they felt they were giving a gift to those who paid attention
Notice how $ACMB stopped with the marketing materials
Black out period. Seems like we’re getting close now
Pulled this from a video on their YouTube posted today. Not much else to share just patiently holding with the OGs
@WINNER4LIFEE I think it’s black out period now they stopped making Youtube videos
Would be insane if they were able to list this 24/7 and have crypto holders be able to buy and run this thing up to $4 for the NASDAQ uplist
@JolTrades@AscendEX_@RWAwatchlist_ $ACMB amended their quarterly report yesterday and it went over everyone’s head. It confirms my entire thread above 👀
The 200M restricted share issuance is controlled by the CEO of Kangli Biotech Lee Shih-
Chiang 🤯
Thread about the unicorn of the OTC $ACMB
From the ACMB website, there is a link to 'Starlink Securities'
ACMB website: https://t.co/R9SYdPBc6X
Starlink Securities: https://t.co/pL1BPk2JBr
Starlink six major divisions:
- Underwriting Division
- Proprietary Trading & Investment Division
- USD Asset Trust Division
- Asset Management Division
- Securities Advisory Division
- Real World Asset Underwriting Division
Pay attention to the co-founders. You will get very familiar with them.
Yessir 46.86% I really think they are trying to move things forward without drawing too much attention. Kangli Biotech has over 50 patents so I suspect they will roll many if not all in to $ACMB
Before the amendment it listed the issuance to Twin Ox Holdings Group, Inc (unknown) 🤔
Seems like an odd thing to do
@JolTrades@AscendEX_@RWAwatchlist_ $ACMB amended their quarterly report yesterday and it went over everyone’s head. It confirms my entire thread above 👀
The 200M restricted share issuance is controlled by the CEO of Kangli Biotech Lee Shih-
Chiang 🤯
It's worth noting that $ACMB has devised an innovative business model to optimize and enhance the company's asset value. In addition to providing CDMO services to global brands through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer), ACMB plans to introduce STO (Security Token Offering). By digitizing its "Hamahiga Island Contractual Farm Base" and "patented technologies," ACMB will be able to effectively strengthen its operational momentum, allowing global investors to directly participate in the growth opportunities of the longevity economy. Furthermore, ACMB will launch a highly efficient M&A strategy targeting the Asian, American, and European markets to continuously expand its market share.
Deepening Implementation: Japanese Expert Team Returns Visit to Kaohsiung
As the cooperation accelerates, a team of experts from Japan's Ryukyu Health Foods Co., Ltd. will visit Taiwan this week in return, personally inspecting ACMB's headquarters and burdock production base in Kaohsiung, Taiwan, and touring the Siaogang Food Factory. The Japanese team's trip aims to verify ACMB's automated processes and sterilization technology, ensuring that exported products meet international pharmacopoeia-level standards.
ACMB Chairperson Yu-Chia Chou emphasized, "We are not just selling products; we are building an international biomedical industry moat." When Asia's top-quality materials meet American capital and Taiwan's R&D, ACMB will redefine the international standards of the global longevity industry.
$ACMB nice close. This time around is the float is locked by the ACMB OGs on here that are holding for the NASDAQ listing.
Watch how little volume it takes to get above 10 cents this time. It’ll be volatile too because of how thin it is. Not for the faint of heart
Check my two huge threads this weekend. My pinned tweet which has a link to the video thread
@TVestor3 Check 4th pic below. Will take you half a day to go through my stuff
First pic from the CFO own mouth
“As of February 2, 2026 its market capitalization ($ACMB) totaled US$45M
However, once it reaches the United States, its valuation will be multiplied by at least 300 times”
Best OTC out there hands down IMO. I’m holding and posting about my favourite $ACMB until they go mainboard NASDAQ this year 🔥
13 new herbal medicines. The company says they’re taking this to multi-billion market cap.
Also they’re selling shares at $1 in series C right now 👀
For anyone new to $ACMB go through this thread and my pinned tweet
They are currently selling shares to investors abroad at $1-2 per share I’m pretty sure the $1 round is closed. NASDAQ uplist is the plan.
It’s a load up and hold. The company does not care about the OTC they believe it’s a gift you get to buy. Don’t expect any PR (they PR regularly in Taiwan)